(related to Figure 1 ) Phenotype of in vitro generated effector T cells and analysis of cell death induction by anti-CD3. Flow cytometric analysis of CD8 + T cells at the day of isolation (day 0) and 2 days after anti-CD3+anti-CD28 stimulation, followed by 5 days rest in IL-2 (day 7). (A) Dot plots showing forward scatter vs. side scatter, and CD62L vs. CD44, after gating on the CD8 + population. (B) CD4 + T cells were stimulated for 4 days with anti-CD3+anti-CD28 plus IL-4, IL-2, anti-IFN-γ and anti-IL-12. After 2 days rest in IL-2, cells were unstimulated or stimulated for 6 hr with anti-CD3+anti-CD28 and analyzed by flow cytometry for intracellular IFN-γ and IL-4. Dot plots show cells after gating on the CD4 + population. (C) Histogram of unstimulated (open plot) and 2 hr anti-CD3+anti-CD28 stimulated (closed plot) CD4 + Th2 cells and CD8 + Tcm cells expressing Bcl10-GFP, to assess Bcl10-GFP degradation (leftward shift in peak). Data are representative of three independent experiments. (D) Primary CD4 + Th2 cells were stimulated for the indicated times with anti-CD3+anti-CD28 and stained for endogenous Bcl10. Confocal microscopy was used to detect endogenous Bcl10 in POLKADOTS. (E) D10 T cells were stimulated for 20 min with CH12 B cells loaded with 250 µg/mL conalbumin. Cells were stained with anti-ATG12, and Bcl10-GFP and endogenous ATG12 were visualized by confocal microscopy. Scale bars (D, E) = 10 µm. (F & G) D10 T cells were treated with 1µM staurosporine (positive control to induce cell death) or activated with plate-bound anti-CD3 for the indicated times, followed by immunoblotting with anti-(total) caspase 3 or anti-cleaved casapase 3 (F), or by 7-AAD plus annexin V staining with flow cytometry analysis to quantify T cell death (G). Numbers in quadrants (G) are percent cells in each region. Note that early cell death is detected in the annexin V high 7AAD low quadrant and late cell death is detected in the annexin V high 7AAD high quadrant. Cells were stained with anti-MALT1 and assessed by confocal microscopy for co-localization between proteins. (B) CD4 + Th2 cells were stimulated with anti-CD3+anti-CD28 for the indicated times and stained with anti-Bcl10 and anti-p62. Cells were analyzed by confocal microscopy for co-localization between p62 and Bcl10. (C) D10 T cells were stimulated for 20 min with CH12 B cells loaded with no antigen (No Ag) or with 250 µg/mL conalbumin (+ Antigen). Cells were stained with anti-p62, followed by an Alexa-555 secondary antibody (Al.555). Bcl10-GFP and endogenous p62 were visualized by confocal microscopy. (D) D10 T cells expressing Bcl10-GFP were stimulated with anti-CD3 for 20 min. Cells were stained with an anti-NBR1, followed by an Alexa-555 secondary antibody (Al.555), and imaged by confocal microscopy to assess colocalization between Bcl10 and NBR1. Scale bar = 10 µm. Figure 3 ) p62 silencing inhibits formation of Bcl10 POLKADOTS and blocks IKK activation, but does not affect ERK1/2 phosphorylation. (A) D10 T cells expressing Bcl10-GFP (D10/Bcl10-GFP) and p62shRNA were stimulated with anti-CD3 for 20 min, stained with anti-p62, and analyzed by confocal microscopy. Red arrow points to a cell with residual p62 expression, which also demonstrates Bcl10-GFP clustering. There is no clustering of Bcl10-GFP in cells with efficient p62 silencing. (B) D10 T cells expressing Bcl10-GFP and infected with the empty shRNA vector (D10/Bcl10-GFP control) or expressing Bcl10-GFP and infected with the p62shRNA vector (D10/Bcl10-GFP p62shRNA) were stimulated for the indicated times with anti-CD3. Cells were analyzed by immunoblotting for Bcl10-GFP degradation, phosphorylation of ERK1 and ERK2, silencing of p62, and for levels of GAPDH (a loading control). (C) D10 T cells infected with the empty shRNA vector (control) or with the vector expressing the p62shRNA were stimulated for the indicated times with anti-CD3. Cells were analyzed by immunoblotting for endogenous Bcl10 degradation, IKKα/β phosphorylation, p62 silencing, and Tubulin expression (loading control). * indicates non-specific band. Scale bar = 10 µm. Figure 4 ) Inhibition of Bcl10 K63-polyubiquitination does not affect ERK1 and ERK2 phosphorylation. D10 T cells expressing either Bcl10-WT-GFP or Bcl10-KK.RR-GFP were stimulated with anti-CD3 for the indicated times. Cells were lysed and assessed by immunoblotting for ERK phosphorylation, Bcl10 degradation, and GAPDH levels.
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